Luye is a Shanghai-based pharmaceutical company that develops medicines for the treatment of cancer, cardiovascular and metabolism diseases.
Business Model:
Revenue: $910.1M
Employees: 1,001-5,000
Luye was acquired by
MBK Partners.
The acquisition happend on 2008-04-01.
Details of the transaction were not public
Address: No. 1036 Tianlin RD
City: Shanghai
State: shanghai municipality
Zip: 200233
Country: CN
Luye is a Shanghai-based pharmaceutical company that develops medicines for the treatment of cancer, cardiovascular and metabolism diseases.
Contact Phone:
Contact Email:
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
5/14/2004
Ticker Symbol:
2186
IPO Price:
$5/share
Amount Raised:
$764M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2022 | Lituo Biotechnology | Seed Round | - |
11/2016 | LeEco | Series C | 0 |
11/2017 | Exicure | Private Placement | 11.2M |
11/2017 | Exicure | Venture Round | 0 |
11/2016 | LeEco | Series C | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2021 | Private Equity Round | $309.6M |
Hillhouse Capital Group |
---|
Announced Date | Name | Price |
---|---|---|
7/2016 | ACINO |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|